• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1(GLP-1)对分离的人胰岛激素分泌的影响。

The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.

作者信息

Fehmann H C, Hering B J, Wolf M J, Brandhorst H, Brandhorst D, Bretzel R G, Federlin K, Göke B

机构信息

Department of Medicine, Philipps-University of Marburg, Germany.

出版信息

Pancreas. 1995 Aug;11(2):196-200. doi: 10.1097/00006676-199508000-00014.

DOI:10.1097/00006676-199508000-00014
PMID:7479679
Abstract

Glucagon-like peptide-I (GLP-I) is a potent incretin hormone that is now considered as a new therapeutic tool in the treatment of diabetes mellitus. In this study we characterized the effects of GLP-I on peptide hormone release from isolated human pancreatic islets. GLP-I stimulated insulin release in the presence of 10 mM glucose (2.8 mM glucose, 100%; 10 mM glucose, 166%; 10 mM glucose + 10 nM GLP-I, 222%) but had only a weak insulinotropic effect (128%) at 2.8 mM glucose. Glucagon release was inhibited by 10 mM glucose (2.8 mM glucose, 100%; 10 mM glucose, 72%) and by 10 nM GLP-I at 2.8 mM glucose (67%). Somatostatin secretion was increased by 10 mM glucose (2.8 mM glucose, 100%; 10 mM glucose, 166%). GLP-I stimulated somatostatin release in the presence of 2.8 mM glucose (172%). Pancreatic polypeptide (PP) secretion was enhanced by 10 mM glucose (2.8 mM glucose, 100%; 10 mM glucose, 236%). GLP-I induced PP release only in the presence of 2.8 mM glucose (184%).

摘要

胰高血糖素样肽 -1(GLP -1)是一种强效的肠促胰岛素激素,目前被视为治疗糖尿病的一种新的治疗工具。在本研究中,我们描述了GLP -1对分离的人胰岛中肽类激素释放的影响。GLP -1在10 mM葡萄糖存在下刺激胰岛素释放(2.8 mM葡萄糖时为100%;10 mM葡萄糖时为166%;10 mM葡萄糖 + 10 nM GLP -1时为222%),但在2.8 mM葡萄糖时仅具有微弱的促胰岛素作用(128%)。胰高血糖素释放在10 mM葡萄糖时受到抑制(2.8 mM葡萄糖时为100%;10 mM葡萄糖时为72%),在2.8 mM葡萄糖时受到10 nM GLP -1的抑制(67%)。生长抑素分泌在10 mM葡萄糖时增加(2.8 mM葡萄糖时为100%;10 mM葡萄糖时为166%)。GLP -1在2.8 mM葡萄糖存在下刺激生长抑素释放(172%)。胰多肽(PP)分泌在10 mM葡萄糖时增强(2.8 mM葡萄糖时为100%;10 mM葡萄糖时为236%)。GLP -1仅在2.8 mM葡萄糖存在时诱导PP释放(184%)。

相似文献

1
The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.胰高血糖素样肽-1(GLP-1)对分离的人胰岛激素分泌的影响。
Pancreas. 1995 Aug;11(2):196-200. doi: 10.1097/00006676-199508000-00014.
2
Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.胰高血糖素样肽-1(GLP-1)受体在大鼠个体发育过程中的表达及GLP-1-(7-36)酰胺对胰岛胰岛素释放的影响。
Eur J Biochem. 2001 Feb;268(3):514-20. doi: 10.1046/j.1432-1327.2001.01865.x.
3
Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.肽能对胎儿胰岛β细胞刺激-分泌偶联成熟的调节作用。
Pancreas. 2000 Apr;20(3):282-9. doi: 10.1097/00006676-200004000-00010.
4
Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.胃饥饿素衍生肽影响胰岛素、胰高血糖素、胰多肽和生长抑素的分泌:对小鼠和大鼠胰腺分离胰岛的研究。
Regul Pept. 2008 Feb 7;146(1-3):230-7. doi: 10.1016/j.regpep.2007.09.017. Epub 2007 Sep 18.
5
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.艾塞那肽-4和胰高血糖素样肽-1在体内和体外的促胰岛素分泌作用。
Metabolism. 2001 May;50(5):583-9. doi: 10.1053/meta.2001.22519.
6
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.胰高血糖素样肽1抑制细胞凋亡并改善新鲜分离的人胰岛的葡萄糖反应性。
Endocrinology. 2003 Dec;144(12):5149-58. doi: 10.1210/en.2003-0323. Epub 2003 Aug 28.
7
Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.促胰岛素激素胰高血糖素样肽-I(7-37)在一种生长抑素分泌细胞系上的功能性受体。
FEBS Lett. 1991 Feb 25;279(2):335-40. doi: 10.1016/0014-5793(91)80182-3.
8
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.胰高血糖素样肽I增强了格列本脲对非胰岛素依赖型糖尿病患者及灌注大鼠胰腺的促胰岛素分泌作用。
Diabetes Care. 1996 Aug;19(8):857-63. doi: 10.2337/diacare.19.8.857.
9
Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.胰高血糖素样肽-1(GLP-1)与甘丙肽在胰岛素分泌细胞(βTC-1)和生长抑素分泌细胞(RIN T3)中的相互作用,以及两种肽在胰高血糖素分泌细胞(INR1G9)上均无受体的证据。
Acta Diabetol. 1995 Oct;32(3):176-81. doi: 10.1007/BF00838488.
10
Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.长期培养中,胰高血糖素样肽-1、垂体腺苷酸环化酶激活肽和烟酰胺等刺激物对猪胰腺内分泌细胞葡萄糖刺激的胰岛素分泌的影响。
Pancreas. 2002 Jul;25(1):86-93. doi: 10.1097/00006676-200207000-00019.

引用本文的文献

1
Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets.成年人类胰岛和干细胞衍生胰岛中的β细胞异质性。
Cell Mol Life Sci. 2023 Jun 3;80(6):176. doi: 10.1007/s00018-023-04815-7.
2
Antidiabetic effect of an engineered bacterium -pMG36e -GLP-1 in monkey model.工程菌-pMG36e-GLP-1在猴模型中的抗糖尿病作用。
Synth Syst Biotechnol. 2021 Sep 17;6(4):272-282. doi: 10.1016/j.synbio.2021.09.009. eCollection 2021 Dec.
3
Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.
靶向脂质 GPCR 治疗 2 型糖尿病:进展与挑战。
Nat Rev Endocrinol. 2021 Mar;17(3):162-175. doi: 10.1038/s41574-020-00459-w. Epub 2021 Jan 25.
4
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism.炎症与代谢之间的二肽基肽酶-4
Clin Med Insights Endocrinol Diabetes. 2020 Mar 20;13:1179551420912972. doi: 10.1177/1179551420912972. eCollection 2020.
5
Glucagon-like peptide 1 (GLP-1).胰高血糖素样肽 1(GLP-1)。
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
6
DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.DPP-4 抑制剂作为抗高血压治疗的潜在候选药物:改善血管炎症并辅助传统抗高血压药物的作用。
Front Immunol. 2019 May 9;10:1050. doi: 10.3389/fimmu.2019.01050. eCollection 2019.
7
GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca channels.胰高血糖素样肽-1通过抑制P/Q型钙通道来抑制人胰腺α细胞中的胰高血糖素分泌。
Physiol Rep. 2018 Sep;6(17):e13852. doi: 10.14814/phy2.13852.
8
A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates.一种新型的胰高血糖素相关肽 (GCRP) 及其受体 GCRPR 解释了脊椎动物中其家族成员的共同进化。
PLoS One. 2013 Jun 11;8(6):e65420. doi: 10.1371/journal.pone.0065420. Print 2013.
9
Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction.胰高血糖素样肽-1 及其受体在结构和分子上的保守性赋予了其选择性配体-受体相互作用。
Front Endocrinol (Lausanne). 2012 Nov 19;3:141. doi: 10.3389/fendo.2012.00141. eCollection 2012.
10
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.内源性肠促胰岛素分泌在健康受试者和 2 型糖尿病患者中作为葡萄糖刺激的胰岛素分泌的放大器的作用。
Diabetes. 2012 Sep;61(9):2349-58. doi: 10.2337/db11-1701. Epub 2012 Jun 20.